Global Pharmacovigilance Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Pharmacovigilance market size was valued at US$ 4290.3 million in 2023. With growing demand in downstream market, the Pharmacovigilance is forecast to a readjusted size of US$ 7546.8 million by 2030 with a CAGR of 8.4% during review period.
The research report highlights the growth potential of the global Pharmacovigilance market. Pharmacovigilance are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmacovigilance. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmacovigilance market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmacovigilance market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmacovigilance market. It may include historical data, market segmentation by Type (e.g., Chemotherapy, Contract Outsourcing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmacovigilance market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmacovigilance market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmacovigilance industry. This include advancements in Pharmacovigilance technology, Pharmacovigilance new entrants, Pharmacovigilance new investment, and other innovations that are shaping the future of Pharmacovigilance.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmacovigilance market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmacovigilance product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmacovigilance market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmacovigilance market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmacovigilance market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmacovigilance industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmacovigilance market.
Market Segmentation:
Pharmacovigilance market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Pharmacovigilance market size was valued at US$ 4290.3 million in 2023. With growing demand in downstream market, the Pharmacovigilance is forecast to a readjusted size of US$ 7546.8 million by 2030 with a CAGR of 8.4% during review period.
The research report highlights the growth potential of the global Pharmacovigilance market. Pharmacovigilance are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmacovigilance. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmacovigilance market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmacovigilance market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmacovigilance market. It may include historical data, market segmentation by Type (e.g., Chemotherapy, Contract Outsourcing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmacovigilance market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmacovigilance market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmacovigilance industry. This include advancements in Pharmacovigilance technology, Pharmacovigilance new entrants, Pharmacovigilance new investment, and other innovations that are shaping the future of Pharmacovigilance.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmacovigilance market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmacovigilance product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmacovigilance market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmacovigilance market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmacovigilance market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmacovigilance industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmacovigilance market.
Market Segmentation:
Pharmacovigilance market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Chemotherapy
- Contract Outsourcing
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPO) Firms
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly and Company
- ICON
- Elsevier
- Chiltern
- Atlantic Research Group
- Mapi Group
- Accenture
- Clinquest Group
- GSK
- PRA Health Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacovigilance Market Size 2019-2030
2.1.2 Pharmacovigilance Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmacovigilance Segment by Type
2.2.1 Chemotherapy
2.2.2 Contract Outsourcing
2.3 Pharmacovigilance Market Size by Type
2.3.1 Pharmacovigilance Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
2.4 Pharmacovigilance Segment by Application
2.4.1 Pharma and Biotech Companies
2.4.2 Contract Research Organizations (CROs)
2.4.3 Business Process Outsourcing (BPO) Firms
2.4.4 Others
2.5 Pharmacovigilance Market Size by Application
2.5.1 Pharmacovigilance Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmacovigilance Market Size Market Share by Application (2019-2024)
3 PHARMACOVIGILANCE MARKET SIZE BY PLAYER
3.1 Pharmacovigilance Market Size Market Share by Players
3.1.1 Global Pharmacovigilance Revenue by Players (2019-2024)
3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE BY REGIONS
4.1 Pharmacovigilance Market Size by Regions (2019-2024)
4.2 Americas Pharmacovigilance Market Size Growth (2019-2024)
4.3 APAC Pharmacovigilance Market Size Growth (2019-2024)
4.4 Europe Pharmacovigilance Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmacovigilance Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmacovigilance Market Size by Country (2019-2024)
5.2 Americas Pharmacovigilance Market Size by Type (2019-2024)
5.3 Americas Pharmacovigilance Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacovigilance Market Size by Region (2019-2024)
6.2 APAC Pharmacovigilance Market Size by Type (2019-2024)
6.3 APAC Pharmacovigilance Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacovigilance by Country (2019-2024)
7.2 Europe Pharmacovigilance Market Size by Type (2019-2024)
7.3 Europe Pharmacovigilance Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacovigilance by Region (2019-2024)
8.2 Middle East & Africa Pharmacovigilance Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmacovigilance Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOVIGILANCE MARKET FORECAST
10.1 Global Pharmacovigilance Forecast by Regions (2025-2030)
10.1.1 Global Pharmacovigilance Forecast by Regions (2025-2030)
10.1.2 Americas Pharmacovigilance Forecast
10.1.3 APAC Pharmacovigilance Forecast
10.1.4 Europe Pharmacovigilance Forecast
10.1.5 Middle East & Africa Pharmacovigilance Forecast
10.2 Americas Pharmacovigilance Forecast by Country (2025-2030)
10.2.1 United States Pharmacovigilance Market Forecast
10.2.2 Canada Pharmacovigilance Market Forecast
10.2.3 Mexico Pharmacovigilance Market Forecast
10.2.4 Brazil Pharmacovigilance Market Forecast
10.3 APAC Pharmacovigilance Forecast by Region (2025-2030)
10.3.1 China Pharmacovigilance Market Forecast
10.3.2 Japan Pharmacovigilance Market Forecast
10.3.3 Korea Pharmacovigilance Market Forecast
10.3.4 Southeast Asia Pharmacovigilance Market Forecast
10.3.5 India Pharmacovigilance Market Forecast
10.3.6 Australia Pharmacovigilance Market Forecast
10.4 Europe Pharmacovigilance Forecast by Country (2025-2030)
10.4.1 Germany Pharmacovigilance Market Forecast
10.4.2 France Pharmacovigilance Market Forecast
10.4.3 UK Pharmacovigilance Market Forecast
10.4.4 Italy Pharmacovigilance Market Forecast
10.4.5 Russia Pharmacovigilance Market Forecast
10.5 Middle East & Africa Pharmacovigilance Forecast by Region (2025-2030)
10.5.1 Egypt Pharmacovigilance Market Forecast
10.5.2 South Africa Pharmacovigilance Market Forecast
10.5.3 Israel Pharmacovigilance Market Forecast
10.5.4 Turkey Pharmacovigilance Market Forecast
10.5.5 GCC Countries Pharmacovigilance Market Forecast
10.6 Global Pharmacovigilance Forecast by Type (2025-2030)
10.7 Global Pharmacovigilance Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Information
11.1.2 Eli Lilly and Company Pharmacovigilance Product Offered
11.1.3 Eli Lilly and Company Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eli Lilly and Company Main Business Overview
11.1.5 Eli Lilly and Company Latest Developments
11.2 ICON
11.2.1 ICON Company Information
11.2.2 ICON Pharmacovigilance Product Offered
11.2.3 ICON Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 ICON Main Business Overview
11.2.5 ICON Latest Developments
11.3 Elsevier
11.3.1 Elsevier Company Information
11.3.2 Elsevier Pharmacovigilance Product Offered
11.3.3 Elsevier Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Elsevier Main Business Overview
11.3.5 Elsevier Latest Developments
11.4 Chiltern
11.4.1 Chiltern Company Information
11.4.2 Chiltern Pharmacovigilance Product Offered
11.4.3 Chiltern Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Chiltern Main Business Overview
11.4.5 Chiltern Latest Developments
11.5 Atlantic Research Group
11.5.1 Atlantic Research Group Company Information
11.5.2 Atlantic Research Group Pharmacovigilance Product Offered
11.5.3 Atlantic Research Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Atlantic Research Group Main Business Overview
11.5.5 Atlantic Research Group Latest Developments
11.6 Mapi Group
11.6.1 Mapi Group Company Information
11.6.2 Mapi Group Pharmacovigilance Product Offered
11.6.3 Mapi Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mapi Group Main Business Overview
11.6.5 Mapi Group Latest Developments
11.7 Accenture
11.7.1 Accenture Company Information
11.7.2 Accenture Pharmacovigilance Product Offered
11.7.3 Accenture Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Accenture Main Business Overview
11.7.5 Accenture Latest Developments
11.8 Clinquest Group
11.8.1 Clinquest Group Company Information
11.8.2 Clinquest Group Pharmacovigilance Product Offered
11.8.3 Clinquest Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Clinquest Group Main Business Overview
11.8.5 Clinquest Group Latest Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Pharmacovigilance Product Offered
11.9.3 GSK Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GSK Main Business Overview
11.9.5 GSK Latest Developments
11.10 PRA Health Sciences
11.10.1 PRA Health Sciences Company Information
11.10.2 PRA Health Sciences Pharmacovigilance Product Offered
11.10.3 PRA Health Sciences Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 PRA Health Sciences Main Business Overview
11.10.5 PRA Health Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacovigilance Market Size 2019-2030
2.1.2 Pharmacovigilance Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmacovigilance Segment by Type
2.2.1 Chemotherapy
2.2.2 Contract Outsourcing
2.3 Pharmacovigilance Market Size by Type
2.3.1 Pharmacovigilance Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
2.4 Pharmacovigilance Segment by Application
2.4.1 Pharma and Biotech Companies
2.4.2 Contract Research Organizations (CROs)
2.4.3 Business Process Outsourcing (BPO) Firms
2.4.4 Others
2.5 Pharmacovigilance Market Size by Application
2.5.1 Pharmacovigilance Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmacovigilance Market Size Market Share by Application (2019-2024)
3 PHARMACOVIGILANCE MARKET SIZE BY PLAYER
3.1 Pharmacovigilance Market Size Market Share by Players
3.1.1 Global Pharmacovigilance Revenue by Players (2019-2024)
3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE BY REGIONS
4.1 Pharmacovigilance Market Size by Regions (2019-2024)
4.2 Americas Pharmacovigilance Market Size Growth (2019-2024)
4.3 APAC Pharmacovigilance Market Size Growth (2019-2024)
4.4 Europe Pharmacovigilance Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmacovigilance Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmacovigilance Market Size by Country (2019-2024)
5.2 Americas Pharmacovigilance Market Size by Type (2019-2024)
5.3 Americas Pharmacovigilance Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacovigilance Market Size by Region (2019-2024)
6.2 APAC Pharmacovigilance Market Size by Type (2019-2024)
6.3 APAC Pharmacovigilance Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacovigilance by Country (2019-2024)
7.2 Europe Pharmacovigilance Market Size by Type (2019-2024)
7.3 Europe Pharmacovigilance Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacovigilance by Region (2019-2024)
8.2 Middle East & Africa Pharmacovigilance Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmacovigilance Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOVIGILANCE MARKET FORECAST
10.1 Global Pharmacovigilance Forecast by Regions (2025-2030)
10.1.1 Global Pharmacovigilance Forecast by Regions (2025-2030)
10.1.2 Americas Pharmacovigilance Forecast
10.1.3 APAC Pharmacovigilance Forecast
10.1.4 Europe Pharmacovigilance Forecast
10.1.5 Middle East & Africa Pharmacovigilance Forecast
10.2 Americas Pharmacovigilance Forecast by Country (2025-2030)
10.2.1 United States Pharmacovigilance Market Forecast
10.2.2 Canada Pharmacovigilance Market Forecast
10.2.3 Mexico Pharmacovigilance Market Forecast
10.2.4 Brazil Pharmacovigilance Market Forecast
10.3 APAC Pharmacovigilance Forecast by Region (2025-2030)
10.3.1 China Pharmacovigilance Market Forecast
10.3.2 Japan Pharmacovigilance Market Forecast
10.3.3 Korea Pharmacovigilance Market Forecast
10.3.4 Southeast Asia Pharmacovigilance Market Forecast
10.3.5 India Pharmacovigilance Market Forecast
10.3.6 Australia Pharmacovigilance Market Forecast
10.4 Europe Pharmacovigilance Forecast by Country (2025-2030)
10.4.1 Germany Pharmacovigilance Market Forecast
10.4.2 France Pharmacovigilance Market Forecast
10.4.3 UK Pharmacovigilance Market Forecast
10.4.4 Italy Pharmacovigilance Market Forecast
10.4.5 Russia Pharmacovigilance Market Forecast
10.5 Middle East & Africa Pharmacovigilance Forecast by Region (2025-2030)
10.5.1 Egypt Pharmacovigilance Market Forecast
10.5.2 South Africa Pharmacovigilance Market Forecast
10.5.3 Israel Pharmacovigilance Market Forecast
10.5.4 Turkey Pharmacovigilance Market Forecast
10.5.5 GCC Countries Pharmacovigilance Market Forecast
10.6 Global Pharmacovigilance Forecast by Type (2025-2030)
10.7 Global Pharmacovigilance Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Information
11.1.2 Eli Lilly and Company Pharmacovigilance Product Offered
11.1.3 Eli Lilly and Company Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eli Lilly and Company Main Business Overview
11.1.5 Eli Lilly and Company Latest Developments
11.2 ICON
11.2.1 ICON Company Information
11.2.2 ICON Pharmacovigilance Product Offered
11.2.3 ICON Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 ICON Main Business Overview
11.2.5 ICON Latest Developments
11.3 Elsevier
11.3.1 Elsevier Company Information
11.3.2 Elsevier Pharmacovigilance Product Offered
11.3.3 Elsevier Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Elsevier Main Business Overview
11.3.5 Elsevier Latest Developments
11.4 Chiltern
11.4.1 Chiltern Company Information
11.4.2 Chiltern Pharmacovigilance Product Offered
11.4.3 Chiltern Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Chiltern Main Business Overview
11.4.5 Chiltern Latest Developments
11.5 Atlantic Research Group
11.5.1 Atlantic Research Group Company Information
11.5.2 Atlantic Research Group Pharmacovigilance Product Offered
11.5.3 Atlantic Research Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Atlantic Research Group Main Business Overview
11.5.5 Atlantic Research Group Latest Developments
11.6 Mapi Group
11.6.1 Mapi Group Company Information
11.6.2 Mapi Group Pharmacovigilance Product Offered
11.6.3 Mapi Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mapi Group Main Business Overview
11.6.5 Mapi Group Latest Developments
11.7 Accenture
11.7.1 Accenture Company Information
11.7.2 Accenture Pharmacovigilance Product Offered
11.7.3 Accenture Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Accenture Main Business Overview
11.7.5 Accenture Latest Developments
11.8 Clinquest Group
11.8.1 Clinquest Group Company Information
11.8.2 Clinquest Group Pharmacovigilance Product Offered
11.8.3 Clinquest Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Clinquest Group Main Business Overview
11.8.5 Clinquest Group Latest Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Pharmacovigilance Product Offered
11.9.3 GSK Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GSK Main Business Overview
11.9.5 GSK Latest Developments
11.10 PRA Health Sciences
11.10.1 PRA Health Sciences Company Information
11.10.2 PRA Health Sciences Pharmacovigilance Product Offered
11.10.3 PRA Health Sciences Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 PRA Health Sciences Main Business Overview
11.10.5 PRA Health Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmacovigilance Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Contract Outsourcing
Table 4. Pharmacovigilance Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 7. Pharmacovigilance Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 10. Global Pharmacovigilance Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Pharmacovigilance Revenue Market Share by Player (2019-2024)
Table 12. Pharmacovigilance Key Players Head office and Products Offered
Table 13. Pharmacovigilance Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Pharmacovigilance Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Pharmacovigilance Market Size Market Share by Regions (2019-2024)
Table 18. Global Pharmacovigilance Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Pharmacovigilance Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Pharmacovigilance Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Pharmacovigilance Market Size Market Share by Country (2019-2024)
Table 22. Americas Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 24. Americas Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 26. APAC Pharmacovigilance Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Pharmacovigilance Market Size Market Share by Region (2019-2024)
Table 28. APAC Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 30. APAC Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 32. Europe Pharmacovigilance Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Pharmacovigilance Market Size Market Share by Country (2019-2024)
Table 34. Europe Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 36. Europe Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Pharmacovigilance Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Pharmacovigilance Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Pharmacovigilance
Table 45. Key Market Challenges & Risks of Pharmacovigilance
Table 46. Key Industry Trends of Pharmacovigilance
Table 47. Global Pharmacovigilance Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Pharmacovigilance Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Pharmacovigilance Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Pharmacovigilance Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Eli Lilly and Company Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 52. Eli Lilly and Company Pharmacovigilance Product Offered
Table 53. Eli Lilly and Company Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Eli Lilly and Company Main Business
Table 55. Eli Lilly and Company Latest Developments
Table 56. ICON Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 57. ICON Pharmacovigilance Product Offered
Table 58. ICON Main Business
Table 59. ICON Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. ICON Latest Developments
Table 61. Elsevier Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 62. Elsevier Pharmacovigilance Product Offered
Table 63. Elsevier Main Business
Table 64. Elsevier Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Elsevier Latest Developments
Table 66. Chiltern Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 67. Chiltern Pharmacovigilance Product Offered
Table 68. Chiltern Main Business
Table 69. Chiltern Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Chiltern Latest Developments
Table 71. Atlantic Research Group Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 72. Atlantic Research Group Pharmacovigilance Product Offered
Table 73. Atlantic Research Group Main Business
Table 74. Atlantic Research Group Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Atlantic Research Group Latest Developments
Table 76. Mapi Group Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 77. Mapi Group Pharmacovigilance Product Offered
Table 78. Mapi Group Main Business
Table 79. Mapi Group Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Mapi Group Latest Developments
Table 81. Accenture Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 82. Accenture Pharmacovigilance Product Offered
Table 83. Accenture Main Business
Table 84. Accenture Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Accenture Latest Developments
Table 86. Clinquest Group Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 87. Clinquest Group Pharmacovigilance Product Offered
Table 88. Clinquest Group Main Business
Table 89. Clinquest Group Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Clinquest Group Latest Developments
Table 91. GSK Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 92. GSK Pharmacovigilance Product Offered
Table 93. GSK Main Business
Table 94. GSK Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. GSK Latest Developments
Table 96. PRA Health Sciences Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 97. PRA Health Sciences Pharmacovigilance Product Offered
Table 98. PRA Health Sciences Main Business
Table 99. PRA Health Sciences Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. PRA Health Sciences Latest Developments
Table 1. Pharmacovigilance Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Contract Outsourcing
Table 4. Pharmacovigilance Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 7. Pharmacovigilance Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 10. Global Pharmacovigilance Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Pharmacovigilance Revenue Market Share by Player (2019-2024)
Table 12. Pharmacovigilance Key Players Head office and Products Offered
Table 13. Pharmacovigilance Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Pharmacovigilance Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Pharmacovigilance Market Size Market Share by Regions (2019-2024)
Table 18. Global Pharmacovigilance Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Pharmacovigilance Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Pharmacovigilance Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Pharmacovigilance Market Size Market Share by Country (2019-2024)
Table 22. Americas Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 24. Americas Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 26. APAC Pharmacovigilance Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Pharmacovigilance Market Size Market Share by Region (2019-2024)
Table 28. APAC Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 30. APAC Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 32. Europe Pharmacovigilance Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Pharmacovigilance Market Size Market Share by Country (2019-2024)
Table 34. Europe Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 36. Europe Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Pharmacovigilance Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Pharmacovigilance Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Pharmacovigilance Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmacovigilance Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Pharmacovigilance Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmacovigilance Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Pharmacovigilance
Table 45. Key Market Challenges & Risks of Pharmacovigilance
Table 46. Key Industry Trends of Pharmacovigilance
Table 47. Global Pharmacovigilance Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Pharmacovigilance Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Pharmacovigilance Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Pharmacovigilance Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Eli Lilly and Company Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 52. Eli Lilly and Company Pharmacovigilance Product Offered
Table 53. Eli Lilly and Company Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Eli Lilly and Company Main Business
Table 55. Eli Lilly and Company Latest Developments
Table 56. ICON Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 57. ICON Pharmacovigilance Product Offered
Table 58. ICON Main Business
Table 59. ICON Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. ICON Latest Developments
Table 61. Elsevier Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 62. Elsevier Pharmacovigilance Product Offered
Table 63. Elsevier Main Business
Table 64. Elsevier Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Elsevier Latest Developments
Table 66. Chiltern Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 67. Chiltern Pharmacovigilance Product Offered
Table 68. Chiltern Main Business
Table 69. Chiltern Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Chiltern Latest Developments
Table 71. Atlantic Research Group Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 72. Atlantic Research Group Pharmacovigilance Product Offered
Table 73. Atlantic Research Group Main Business
Table 74. Atlantic Research Group Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Atlantic Research Group Latest Developments
Table 76. Mapi Group Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 77. Mapi Group Pharmacovigilance Product Offered
Table 78. Mapi Group Main Business
Table 79. Mapi Group Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Mapi Group Latest Developments
Table 81. Accenture Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 82. Accenture Pharmacovigilance Product Offered
Table 83. Accenture Main Business
Table 84. Accenture Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Accenture Latest Developments
Table 86. Clinquest Group Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 87. Clinquest Group Pharmacovigilance Product Offered
Table 88. Clinquest Group Main Business
Table 89. Clinquest Group Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Clinquest Group Latest Developments
Table 91. GSK Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 92. GSK Pharmacovigilance Product Offered
Table 93. GSK Main Business
Table 94. GSK Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. GSK Latest Developments
Table 96. PRA Health Sciences Details, Company Type, Pharmacovigilance Area Served and Its Competitors
Table 97. PRA Health Sciences Pharmacovigilance Product Offered
Table 98. PRA Health Sciences Main Business
Table 99. PRA Health Sciences Pharmacovigilance Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. PRA Health Sciences Latest Developments
LIST OF FIGURES
Figure 1. Pharmacovigilance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacovigilance Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmacovigilance Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmacovigilance Sales Market Share by Country/Region (2023)
Figure 8. Pharmacovigilance Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmacovigilance Market Size Market Share by Type in 2023
Figure 10. Pharmacovigilance in Pharma and Biotech Companies
Figure 11. Global Pharmacovigilance Market: Pharma and Biotech Companies (2019-2024) & ($ Millions)
Figure 12. Pharmacovigilance in Contract Research Organizations (CROs)
Figure 13. Global Pharmacovigilance Market: Contract Research Organizations (CROs) (2019-2024) & ($ Millions)
Figure 14. Pharmacovigilance in Business Process Outsourcing (BPO) Firms
Figure 15. Global Pharmacovigilance Market: Business Process Outsourcing (BPO) Firms (2019-2024) & ($ Millions)
Figure 16. Pharmacovigilance in Others
Figure 17. Global Pharmacovigilance Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Pharmacovigilance Market Size Market Share by Application in 2023
Figure 19. Global Pharmacovigilance Revenue Market Share by Player in 2023
Figure 20. Global Pharmacovigilance Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 22. APAC Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 23. Europe Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 25. Americas Pharmacovigilance Value Market Share by Country in 2023
Figure 26. United States Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Pharmacovigilance Market Size Market Share by Region in 2023
Figure 31. APAC Pharmacovigilance Market Size Market Share by Type in 2023
Figure 32. APAC Pharmacovigilance Market Size Market Share by Application in 2023
Figure 33. China Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Pharmacovigilance Market Size Market Share by Country in 2023
Figure 40. Europe Pharmacovigilance Market Size Market Share by Type (2019-2024)
Figure 41. Europe Pharmacovigilance Market Size Market Share by Application (2019-2024)
Figure 42. Germany Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Pharmacovigilance Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Pharmacovigilance Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Pharmacovigilance Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 56. APAC Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 57. Europe Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 59. United States Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 60. Canada Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 63. China Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 64. Japan Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 65. Korea Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 67. India Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 68. Australia Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 69. Germany Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 70. France Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 71. UK Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 72. Italy Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 73. Russia Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 74. Spain Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 77. Israel Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 80. Global Pharmacovigilance Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Pharmacovigilance Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Pharmacovigilance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacovigilance Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmacovigilance Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmacovigilance Sales Market Share by Country/Region (2023)
Figure 8. Pharmacovigilance Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmacovigilance Market Size Market Share by Type in 2023
Figure 10. Pharmacovigilance in Pharma and Biotech Companies
Figure 11. Global Pharmacovigilance Market: Pharma and Biotech Companies (2019-2024) & ($ Millions)
Figure 12. Pharmacovigilance in Contract Research Organizations (CROs)
Figure 13. Global Pharmacovigilance Market: Contract Research Organizations (CROs) (2019-2024) & ($ Millions)
Figure 14. Pharmacovigilance in Business Process Outsourcing (BPO) Firms
Figure 15. Global Pharmacovigilance Market: Business Process Outsourcing (BPO) Firms (2019-2024) & ($ Millions)
Figure 16. Pharmacovigilance in Others
Figure 17. Global Pharmacovigilance Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Pharmacovigilance Market Size Market Share by Application in 2023
Figure 19. Global Pharmacovigilance Revenue Market Share by Player in 2023
Figure 20. Global Pharmacovigilance Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 22. APAC Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 23. Europe Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Pharmacovigilance Market Size 2019-2024 ($ Millions)
Figure 25. Americas Pharmacovigilance Value Market Share by Country in 2023
Figure 26. United States Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Pharmacovigilance Market Size Market Share by Region in 2023
Figure 31. APAC Pharmacovigilance Market Size Market Share by Type in 2023
Figure 32. APAC Pharmacovigilance Market Size Market Share by Application in 2023
Figure 33. China Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Pharmacovigilance Market Size Market Share by Country in 2023
Figure 40. Europe Pharmacovigilance Market Size Market Share by Type (2019-2024)
Figure 41. Europe Pharmacovigilance Market Size Market Share by Application (2019-2024)
Figure 42. Germany Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Pharmacovigilance Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Pharmacovigilance Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Pharmacovigilance Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Pharmacovigilance Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 56. APAC Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 57. Europe Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 59. United States Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 60. Canada Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 63. China Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 64. Japan Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 65. Korea Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 67. India Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 68. Australia Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 69. Germany Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 70. France Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 71. UK Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 72. Italy Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 73. Russia Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 74. Spain Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 77. Israel Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Pharmacovigilance Market Size 2025-2030 ($ Millions)
Figure 80. Global Pharmacovigilance Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Pharmacovigilance Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Trolley Veterinary Anesthesia Machine Market Growth 2023-2029
US$ 3,660.00
February 2023
112 pages
Global Veterinary Biostimulation Laser Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
116 pages
Global Pet Drug and Vaccine Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
102 pages
Global Corneal Topography System Market Growth 2024-2030
US$ 3,660.00
November 2024
94 pages
Global Cancer Ablation Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
113 pages
